Identification of transcripts modulated by ETV6 expression

British Journal of Haematology

Volumn 136, Issue 1, 2007, Pages 48-62

  Boily, Gino ^a   Larose, Josiane ^a   Langlois, Sylvie ^a   Sinnett, Daniel ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Clinical outcomes; ETV6; Leukaemia; Microarrays; Transcriptional targets

Indexed keywords

ABC TRANSPORTER; COMPLEMENTARY DNA; INTERLEUKIN 18; PROTEIN P53; SPHINGOSINE KINASE 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ETV6; UBIQUITIN; VASCULOTROPIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW; CHILD; CHROMOSOME DELETION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE INDUCTION; GENE TARGETING; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; MALE; PRE B LYMPHOCYTE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; TUMOR SUPPRESSOR GENE;

ANIMALS; BINDING SITES; CONSERVED SEQUENCE; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HUMANS; IMMUNOBLOTTING; LEUKEMIA, LYMPHOCYTIC, ACUTE, L1; LEUKEMIA, PRE-B-CELL; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC; TRANSFECTION;

EID: 33845481383     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2006.06377.x     Document Type: Article

References (67)

1. Aissani, B. & Sinnett, D. (1999) Fine physical and transcript mapping of a 1.8 Mb region spanning the locus for childhood acute lymphoblastic leukemia on chromosome 12p12.3. Gene, 240, 297-305.
2. Aissani, B., Bonan, C., Baccichet, A. & Sinnett, D. (1999) Childhood acute lymphoblastic leukemia: is there a tumor suppressor gene in chromosome 12p12.3? Leukemia and Lymphoma, 34, 231-239.
3. Akamatsu, S., Arai, N., Hanaya, T., Arai, S., Tanimoto, T., Fujii, M., Kohno, K., Micallef, M.J., Ikeda, M. & Kurimoto, M. (2002) Antitumor activity of interleukin-18 against the murine T-cell leukemia/lymphoma EL-4 in syngeneic mice. Journal of Immunotherapy, 25 (Suppl. 1), S28-S34.
4. Baccichet, A. & Sinnett, D. (1997) Frequent deletion of chromosome 12p12.3 in children with acute lymphoblastic leukaemia. British Journal of Haematology, 99, 107-114.
5. Baens, M., Wlodarska, I., Corveleyn, A., Hoornaert, I., Hagemeijer, A. & Marynen, P. (1999) A physical, transcript, and deletion map of chromosome region 12p12.3 flanked by ETV6 and CDKN1B: hypermethylation of the LRP6 CpG island in two leukemia patients with hemizygous del(12p). Genomics, 56, 40-50.
6. Baxevanis, C.N., Gritzapis, A.D. & Papamichail, M. (2003) In vivo antitumor activity of NKT cells activated by the combination of IL-12 and IL-18. Journal of Immunology, 171, 2953-2959.
7. Boily, G. & Sinnett, D. (2002) Functionnal Characterization of ETV6, a Candidate Tumor Suppressor Gene Associated with Acute Lymphoblastic Leukemia. Beyond the Identification of Transcribed Sequences: Functional, Evolutionary and Expression Analysis. 12th International Workshop, October 25-28, 2002. Washington, DC.
8. Brown, D.M., Warner, G.L., Ales-Martinez, J.E., Scott, D.W. & Phipps, R.P. (1992) Prostaglandin E2 induces apoptosis in immature normal and malignant B lymphocytes. Clinical Immunology and Immunopathology, 63, 221-229.
9. Chakrabarti, S.R. & Nucifora, G. (1999) The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A. Biochemical and Biophysical Research Communications, 264, 871-877.
10. Chakravarti, S. (2002) Functions of lumican and fibromodulin: lessons from knockout mice. Glycoconjugate Journal, 19, 287-293.
11. Coughlin, C.M., Salhany, K.E., Wysocka, M., Aruga, E., Kurzawa, H., Chang, A.E., Hunter, C.A., Fox, J.C., Trinchieri, G. & Lee, W.M. (1998) Interleukin-12 and interleukin-18 synergistically induce murine tumor regression which involves inhibition of angiogenesis. Journal of Clinical Investigation, 101, 1441-1452.
12. Cuvillier, O. & Levade, T. (2001) Sphingosine 1-phosphate antagonizes apoptosis of human leukemia cells by inhibiting release of cytochrome c and Smac/DIABLO from mitochondria. Blood, 98, 2828-2836.
13. Cuvillier, O., Rosenthal, D.S., Smulson, M.E. & Spiegel, S. (1998) Sphingosine 1-phosphate inhibits activation of caspases that cleave poly(ADP-ribose) polymerase and lamins during Fas- and ceramide-mediated apoptosis in Jurkat T lymphocytes. Journal of Biological Chemistry, 273, 2910-2916.
14. Fears, S., Gavin, M., Zhang, D.E., Hetherington, C., Ben-David, Y., Rowley, J.D. & Nucifora, G. (1997) Functional characterization of ETV6 and ETV6/CBFA2 in the regulation of the MCSFR proximal promoter. Proceedings of the National Academy of Sciences of the United States of America, 94, 1949-1954.
15. Fedyk, E.R., Ripper, J.M., Brown, D.M. & Phipps, R.P. (1996) A molecular analysis of PGE receptor (EP) expression on normal and transformed B lymphocytes: coexpression of EP1, EP2, EP3beta and EP4. Molecular Immunology, 33, 33-45.
16. Fenrick, R., Wang, L., Nip, J., Amann, J.M., Rooney, R.J., Walker-Daniels, J., Crawford, H.C., Hulboy, D.L., Kinch, M.S., Matrisian, L.M. & Hiebert, S.W. (2000) TEL, a putative tumor suppressor, modulates cell growth and cell morphology of ras-transformed cells while repressing the transcription of stromelysin-1. Molecular and Cellular Biology, 20, 5828-5839.
17. Grover, J., Liu, C.Y., Kao, W.W. & Roughley, P.J. (2000) Analysis of the human lumican gene promoter. Journal of Biological Chemistry, 275, 40967-40973.
18. Gump, J., McGavran, L., Wei, Q. & Hunger, S.P. (2001) Analysis of TP53 mutations in relapsed childhood acute lymphoblastic leukemia. Journal of Pediatric Hematology/Oncology, 23, 416-419.
19. Guo, B., Godzik, A. & Reed, J.C. (2001) Bcl-G, a novel pro-apoptotic member of the Bcl-2 family. Journal of Biological Chemistry, 276, 2780-2785.
20. Hla, T. (2004) Physiological and pathological actions of sphingosine 1-phosphate. Seminars in Cell & Developmental Biology, 15, 513-520.
21. Hock, H., Meade, E., Medeiros, S., Schindler, J.W., Valk, P.J., Fujiwara, Y. & Orkin, S.H. (2004) Tel/Etv6 is an essential and selective regulator of adult hematopoietic stem cell survival. Genes and Development, 18, 2336-2341.
22. Howe, L.R., Crawford, H.C., Subbaramaiah, K., Hassell, J.A., Dannenberg, A.J. & Brown, A.M. (2001) PEA3 is up-regulated in response to Wnt1 and activates the expression of cyclooxygenase-2. Journal of Biological Chemistry, 276, 20108-20115.
23. Irvin, B.J., Wood, L.D., Wang, L., Fenrick, R., Sansam, C.G., Packham, G., Kinch, M., Yang, E. & Hiebert, S.W. (2003) TEL, a putative tumor suppressor, induces apoptosis and represses transcription of Bcl-XL. Journal of Biological Chemistry, 278, 46378-46386.
24. Johansson, N. & Kahari, V.M. (2000) Matrix metalloproteinases in squamous cell carcinoma. Histology and Histopathology, 15, 225-237.
25. Ju, D.W., Yang, Y., Tao, Q., Song, W.G., He, L., Chen, G., Gu, S., Ting, C.C. & Cao, X. (2000) Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity. Gene Therapy, 7, 1672-1679.
26. Kishida, T., Asada, H., Satoh, E., Tanaka, S., Shinya, M., Hirai, H., Iwai, M., Tahara, H., Imanishi, J. & Mazda, O. (2001) In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice. Gene Therapy, 8, 1234-1240.
27. Krug, U., Ganser, A. & Koeffler, H.P. (2002) Tumor suppressor genes in normal and malignant hematopoiesis. Oncogene, 21, 3475-3495.
28. Kuwata, T., Gongora, C., Kanno, Y., Sakaguchi, K., Tamura, T., Kanno, T., Basrur, V., Martinez, R., Appella, E., Golub, T. & Ozato, K. (2002) Gamma interferon triggers interaction between ICSBP (IRF-8) and TEL, recruiting the histone deacetylase HDAC3 to the interferon-responsive element. Molecular and Cellular Biology, 22, 7439-7448.
29. Kwiatkowski, B.A., Bastian, L.S., Bauer, T.R., Jr, Tsai, S., Zielinska-Kwiatkowska, A.G. & Hickstein, D.D. (1998) The ets family member Tel binds to the Fli-1 oncoprotein and inhibits its transcriptional activity. Journal of Biological Chemistry, 273, 17525-17530.
30. Leygue, E., Snell, L., Dotzlaw, H., Hole, K., Hiller-Hitchcock, T., Roughley, P.J., Watson, P.H. & Murphy, L.C. (1998) Expression of lumican in human breast carcinoma. Cancer Research, 58, 1348-1352.
31. Liu, Y., Borchert, G.L. & Phang, J.M. (2004) Polyoma enhancer activator 3, an ets transcription factor, mediates the induction of cyclooxygenase-2 by nitric oxide in colorectal cancer cells. Journal of Biological Chemistry, 279, 18694-18700.
32. Livak, K.J. & Schmittgen, T.D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods, 25, 402-408.
33. Lopez, R.G., Carron, C., Oury, C., Gardellin, P., Bernard, O. & Ghysdael, J. (1999) TEL is a sequence-specific transcriptional repressor. Journal of Biological Chemistry, 274, 30132-30138.
34. Lu, Y.P., Ishiwata, T., Kawahara, K., Watanabe, M., Naito, Z., Moriyama, Y., Sugisaki, Y. & Asano, G. (2002) Expression of lumican in human colorectal cancer cells. Pathology International, 52, 519-526.
35. Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.J., Card, D., Keohane, C., Rosenbach, M., Hale, J., Lynch, C.L., Rupprecht, K., Parsons, W. & Rosen, H. (2002) Alteration of lymphocyte trafficking by sphingosine-1-phosphate receptor agonists. Science, 296, 346-349.
36. Marks, D.I., Kurz, B.W., Link, M.P., Ng, E., Shuster, J.J., Lauer, S.J., Carroll, D., Brodsky, I. & Haines, D.S. (1997) Altered expression of p53 and mdm-2 proteins at diagnosis is associated with early treatment failure in childhood acute lymphoblastic leukemia. Journal of Clinical Oncology, 15, 1158-1162.
37. Mavrothalassitis, G. & Ghysdael, J. (2000) Proteins of the ETS family with transcriptional repressor activity. Oncogene, 19, 6524-6532.
38. Meier-Noorden, M., Flindt, S., Kalinke, U. & Hinz, T. (2004) A CpG-rich bidirectional promoter induces the T-cell death-associated gene 51 and downregulates an inversely oriented transcript during early T-cell activation. Gene, 338, 197-207.
39. Montpetit, A., Boily, G. & Sinnett, D. (2002) A detailed transcriptional map of the chromosome 12p12 tumour suppressor locus. European Journal of Human Genetics, 10, 62-71.
40. Montpetit, A., Larose, J., Boily, G., Langlois, S., Trudel, N. & Sinnett, D. (2004) Mutational and expression analysis of the chromosome 12p candidate tumor suppressor genes in pre-B acute lymphoblastic leukemia. Leukemia, 18, 1499-1504.
41. Naito, Z., Ishiwata, T., Kurban, G., Teduka, K., Kawamoto, Y., Kawahara, K. & Sugisaki, Y. (2002) Expression and accumulation of lumican protein in uterine cervical cancer cells at the periphery of cancer nests. International Journal of Oncology, 20, 943-948.
42. Nordentoft, I. & Jorgensen, P. (2003) The acetyltransferase 60 kDa trans-acting regulatory protein of HIV type 1-interacting protein (Tip60) interacts with the translocation E26 transforming-specific leukaemia gene (TEL) and functions as a transcriptional co-repressor. Biochemical Journal, 374, 165-173.
43. Ohtsuki, T., Micallef, M.J., Kohno, K., Tanimoto, T., Ikeda, M. & Kurimoto, M. (1997) Interleukin 18 enhances Fas ligand expression and induces apoptosis in Fas-expressing human myelomonocytic KG-1 cells. Anticancer Research, 17, 3253-3258.
44. Pica, F., Franzese, O., D'Onofrio, C., Bonmassar, E., Favalli, C. & Garaci, E. (1996) Prostaglandin E2 induces apoptosis in resting immature and mature human lymphocytes: a c-Myc-dependent and Bcl-2-independent associated pathway. Journal of Pharmacology and Experimental Therapeutics, 277, 1793-1800.
45. Ping Lu, Y., Ishiwata, T. & Asano, G. (2002) Lumican expression in alpha cells of islets in pancreas and pancreatic cancer cells. Journal of Pathology, 196, 324-330.
46. Romana, S.P., Le Coniat, M., Poirel, H., Marynen, P., Bernard, O. & Berger, R. (1996) Deletion of the short arm of chromosome 12 is a secondary event in acute lymphoblastic leukemia with t(12;21). Leukemia, 10, 167-170.
47. Rompaey, L.V., Potter, M., Adams, C. & Grosveld, G. (2000) Tel induces a G1 arrest and suppresses Ras-induced transformation. Oncogene, 19, 5244-5250.
48. Sakurai, T., Yamada, T., Kihara-Negishi, F., Teramoto, S., Sato, Y., Izawa, T. & Oikawa, T. (2003) Effects of overexpression of the Ets family transcription factor TEL on cell growth and differentiation of K562 cells. International Journal of Oncology, 22, 1327-1333.
49. Sandelin, A., Wasserman, W.W. & Lenhard, B. (2004) ConSite: web-based prediction of regulatory elements using cross-species comparison. Nucleic Acids Research, 32, W249-252.
50. Shimozato, T. & Kincade, P.W. (1999) Prostaglandin E(2) and stem cell factor can deliver opposing signals to B lymphocyte precursors. Cellular Immunology, 198, 21-29.
51. Spiegel, S. & Kolesnick, R. (2002) Sphingosine 1-phosphate as a therapeutic agent. Leukemia, 16, 1596-1602.
52. Stegmaier, K., Pendse, S., Barker, G.F., Bray-Ward, P., Ward, D.C., Montgomery, K.T., Krauter, K.S., Reynolds, C., Sklar, J. & Donnelly, M. (1995) Frequent loss of heterozygosity at the TEL gene locus in acute lymphoblastic leukemia of childhood. Blood, 86, 38-44.
53. Stegmaier, K., Takeuchi, S., Golub, T.R., Bohlander, S.K., Bartram, C.R. & Koeffler, H.P. (1996) Mutational analysis of the candidate tumor suppressor genes TEL and KIP1 in childhood acute lymphoblastic leukemia. Cancer Research, 56, 1413-1417.
54. Takeuchi, S., Bartram, C.R., Miller, C.W., Reiter, A., Seriu, T., Zimmerann, M., Schrappe, M., Mori, N., Slater, J., Miyoshi, I. & Koeffler, H.P. (1996) Acute lymphoblastic leukemia of childhood: identification of two distinct regions of deletion on the short arm of chromosome 12 in the region of TEL and KIP1. Blood, 87, 3368-3374.
55. Van Rompaey, L., Dou, W., Buijs, A. & Grosveld, G. (1999) Tel, a frequent target of leukemic translocations, induces cellular aggregation and influences expression of extracellular matrix components. Neoplasia, 1, 526-536.
56. Van Rompaey, L., Holland, E. & Grosveld, G. (2002) TEL induces aggregation in transformed cells and induces tube formation in NIH3T3-UCLA cells. Biochemical and Biophysical Research Communications, 291, 820-828.
57. Venanzoni, M.C., Robinson, L.R., Hodge, D.R., Kola, I. & Seth, A. (1996) ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction. Oncogene, 12, 1199-1204.
58. Vij, N., Roberts, L., Joyce, S. & Chakravarti, S. (2004) Lumican suppresses cell proliferation and aids Fas-Fas ligand mediated apoptosis: implications in the cornea. Experimental Eye Research, 78, 957-971.
59. Vuillermoz, B., Khoruzhenko, A., D'Onofrio, M.F., Ramont, L., Venteo, L., Perreau, C., Antonicelli, F., Maquart, F.X. & Wegrowski, Y. (2004) The small leucine-rich proteoglycan lumican inhibits melanoma progression. Experimental Cell Research, 296, 294-306.
60. Wang, L. & Hiebert, S.W. (2001) TEL contacts multiple co-repressors and specifically associates with histone deacetylase-3. Oncogene, 20, 3716-3725.
61. Wang, L.C., Kuo, F., Fujiwara, Y., Gilliland, D.G., Golub, T.R. & Orkin, S.H. (1997) Yolk sac angiogenic defect and intra-embryonic apoptosis in mice lacking the Ets-related factor TEL. EMBO Journal, 16, 4374-4383.
62. Xie, J.H., Nomura, N., Koprak, S.L., Quackenbush, E.J., Forrest, M.J. & Rosen, H. (2003) Sphingosine-1-phosphate receptor agonism impairs the efficiency of the local immune response by altering trafficking of naive and antigen-activated CD4+ T cells. Journal of Immunology, 170, 3662-3670.
63. Yamagata, T., Maki, K., Waga, K. & Mitani, K. (2006) TEL/ETV6 induces apoptosis in 32D cells through p53-dependent pathways. Biochemical and Biophysical Research Communications, 347, 517-526.
64. Yamashita, K., Iwasaki, T., Tsujimura, T., Sugihara, A., Yamada, N., Ueda, H., Okamura, H., Futani, H., Maruo, S. & Terada, N. (2002) Interleukin-18 inhibits lodging and subsequent growth of human multiple myeloma cells in the bone marrow. Oncology Reports, 9, 1237-1244.
65. Yang, S.H., Vickers, E., Brehm, A., Kouzarides, T. & Sharrocks, A.D. (2001) Temporal recruitment of the mSin3A-histone deacetylase corepressor complex to the ETS domain transcription factor Elk-1. Molecular and Cellular Biology, 21, 2802-2814.
66. Zhang, B., Wu, K.F., Lin, Y.M., Ma, X.T., Rao, Q., Zheng, G.G., Cao, Z.Y., Li, G. & Song, Y.H. (2004) Gene transfer of pro-IL-18 and IL-1beta converting enzyme cDNA induces potent antitumor effects in L1210 cells. Leukemia, 18, 817-825.
67. Zhou, M., Gu, L., Abshire, T.C., Homans, A., Billett, A.L., Yeager, A.M. & Findley, H.W. (2000) Incidence and prognostic significance of MDM2 oncoprotein overexpression in relapsed childhood acute lymphoblastic leukemia. Leukemia, 14, 61-67.